Skip to Content

Tag: earnings


Also Noted

Great Elm's DME biz exceeds expectations

February 12, 2019HME News Staff

WALTHAM, Mass. - Great Elm Capital Group, which acquired and merged Valley Healthcare Group and Northwest Medical last year, reported that DME generated $13.2 million of revenue, $400,000 of net income and $3.6 million of adjusted EBITDA in the second quarter of 2019, exceeding original expectations. “In addition to driving organic revenue and EBITDA growth, the DME operating team is aggressively working to realize additional, potential synergies by the end of calendar year 2019,” the...

earnings, Great Elm Capital, Northwest Medical, Valley Healthcare Group


Read Full Articlered right arrow icon

News

Earnings season: Inogen, BioScrip, VieMed

November 7, 2018HME News Staff

GOLETA, Calif. - Inogen reported $95.3 million in total revenue for the third quarter of 2018, a 38% increase over the same period last year.Net income was $16.4 million vs. $7.3 million.“The third quarter was another successful quarter for us as we generated strong revenue across all three sales channels,” said CEO Scott Wilkinson. “We are continuing to execute on our strategy to hire additional sales reps and invest in advertising activities to increase consumer awareness as we...

BioScrip, earnings, Inogen, Viemed


Read Full Articlered right arrow icon

Also Noted

Inogen posts big increases, despite seasonally slow quarter

May 1, 2018HME News Staff

GOLETA, Calif. - Inogen on Monday reported total revenues of $79.1 million for the first quarter of 2018, a 50.6% increase compared to the same period in 2017. It reported a net income of $10.8 million vs. $5.8 million. “In what is historically a seasonally slower quarter, we were able to generate record revenues driven by strong sales in both our domestic direct-to-consumer and domestic business-to-business channels,” said CEO Scott Wilkinson. Direct-to-consumer sales rose 67.8% in the...

earnings, Inogen, POC


Read Full Articlered right arrow icon

Vendors

ResMed's Farrell calls Q3 'strong'

April 27, 2018HME News Staff

SAN DIEGO - ResMed reported revenues of $591.6 million for the third quarter of fiscal year 2018, a 15% increase compared to the same quarter last year.It reported revenues of $317.5 million in the United States, Canada and Latin America, a 7% increase, and revenues of $39.9 million from Brightree, a 14% increase. It reported revenues of $234.2 million in Europe, Asia and other markets, a 16% increase.ResMed reported a net income of $110.1 million for the third quarter, a 25% increase compared to...

audit, earnings, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed closes fiscal year with 12% increase in revenues, 3% decrease in net income

August 2, 2017HME News Staff

SAN DIEGO - ResMed has reported revenues of $556.7 million for the fourth quarter ended June 30, a 7% increase over to the same period in 2016. Excluding contributions from Brightree, revenues were $520.5 million, a 6% increase. For the Americas, ResMed reported revenues of $350.2 million for the fourth quarter, an 8% increase over the same period in 2016. Excluding contributions from Brightree, revenues were $314 million, a 6% increase. ResMed reported net income of $101.6 million for the fourth...

earnings, ResMed, sleep therapy


Read Full Articlered right arrow icon

Also Noted

F&P Healthcare grew homecare revenues by 4% in 2017

May 23, 2017HME News Staff

AUCKLAND, New Zealand - Fisher & Paykel Healthcare reported net profit after tax of NZ$169.2 million for the fiscal year ended March 31, 2017, an increase of 18% over the previous year. Operating revenue was NZ$894.4 million, a 10% increase over the previous year, or 14% growth in constant currency. F&P says both were records for the company. By segment, the hospital product group grew revenues by 15% to NZ$500.4 million, or 19% growth in constant currency; and the homecare product group grew revenues...

earnings, Fisher & Paykel, litigation


Read Full Articlered right arrow icon

Also Noted

Inogen sees triple-digit increase in net sales

May 10, 2017HME News Staff

GOLETA, Calif. - Inogen reported total revenues of $52.5 million for the first quarter of 2017, an increase of 22% over the same period last year, and net income of $5.9 million, a 135.3% increase. “We are off to a solid start to 2017,” said Scott Wilkinson, CEO. “We experienced particular strength in our domestic business to business sales channel, where revenues grew 84.2% over the same period in 2016.” Inogen included in its earnings report the news that it has acquired...

earnings, Inogen, POC


Read Full Articlered right arrow icon

Also Noted

Invacare sets stage for cost reductions

May 9, 2017HME News Staff

ELYRIA, Ohio - Invacare reported $231.7 million in net sales for the first quarter of 2017, a 10% decrease compared to the same quarter last year. For its North America/HME business segment, Invacare reported $119.5 million in net sales for the first quarter, a 2.1% decrease. The company says net sales declines for North American/HME were due to the discontinuation of certain product categories and lower sales of respiratory products. It also noted that it discontinued sales of consumer power wheelchairs...

earnings, FDA, Invacare


Read Full Articlered right arrow icon

Vendors

Inogen stays focused on DTC

March 3, 2017Liz Beaulieu, Editor

GOLETA, Calif. - Inogen's B2B business keeps posting the largest numbers, but the company has put a number of wheels in motion to boost its direct-to-consumer business in 2017.For the third quarter in a row, Inogen's domestic B2B sales were the strongest in the fourth quarter, with 69% growth compared to the same period in 2015.“We continue to see more traditional HME providers turning to portable oxygen concentrators to lower their operating costs in the face of reimbursement reductions and,...

earnings, Inogen, Portable oxygen concentrators


Read Full Articlered right arrow icon

Also Noted

Insulet posts 24% increase in revenue

March 3, 2017HME News Staff

BILLERICA, Mass. - Insulet Corp. has reported fourth quarter revenue of $103.6 million, representing year-over-year growth of 24%. Net loss was $9.2 million vs. $15.9 million. Fourth-quarter revenue in the U.S. for Omnipod was $61.3 million, a 17% increase, and internationally, $20.8 million, a 35% increase. Revenue from drug delivery was $19.6 million, a 34% increase. Insulet reported full year revenue of $367 million, representing year-over-year growth of 39%. Net loss was $27.2 million vs. $61.6...

diabetes, earnings, insulet, insulin


Read Full Articlered right arrow icon